Related Experiment Video
Updated: Mar 1, 2026

Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model
Published on: January 21, 2018
Lessons Learned from STEMI Clinical Trials.
Jasrai Gill1, Anish Amin1, Niraj Parekh1
1Department of Medicine, Loyola University Medical Center, 2160 Maywood, IL 60153, USA.
Coronary artery disease mortality is declining due to improved treatments. This review examines evolving management strategies for acute ST-segment elevation myocardial infarction (STEMI) to support evidence-based care.
Area of Science:
- Cardiology
- Public Health
Background:
- Coronary artery disease (CAD) remains a leading cause of death in the US.
- A 2.5% decrease in heart disease mortality was observed from 2009-2010.
- This decline is partly attributed to advancements in treatment and prevention techniques.
Purpose of the Study:
- To review evolving treatment strategies for acute ST-segment elevation myocardial infarction (STEMI).
- To consolidate evidence supporting an evidence-based approach to STEMI management.
Main Methods:
- Literature review of studies on STEMI treatment strategies.
- Analysis of evidence-based approaches in cardiovascular medicine.
Main Results:
- Significant evolution in STEMI management techniques.
- Identification of key studies shaping current evidence-based guidelines.
Conclusions:
- Evolving strategies have improved STEMI care.
- Continued research and evidence-based practice are crucial for reducing CAD mortality.
More Related Videos
Related Concept Videos
Acute Coronary Syndrome I: Introduction
Clinical Trials: Overview
Acute Coronary Syndrome III: Diagnostic Studies
Clinical Trials
There are four phases in a clinical trial. A phase one...
Acute Coronary Syndrome V: Nursing Management
Cardiac Catheterization IV: Nursing Management

